TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03023488

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: flexible ureteroscopy
Description: Flexible ureteroscopy is an endourological procedure performed for kidney stones. The flexible ureteroscope is a device used to reach the renal cavities through the natural urinary tract in a retrograde fashion. During the operation, irrigation fluid is used to expand the cavities to provide space for movement of the device and also to provide clear vision.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Doppler Ultrasound examination
Description: peak systolic velocities (PSV) and end diastolic velocities (EDV) of the arteries will be measured and then resistive index (RI) and pulsatility index (PI) will be calculated.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: laser lithotripsy
Description: The laser fiber extending into the cavities through the working channel of the ureteroscope is used to fragment the stones. Laser energy is generated by the laser machine and transmitted to the stones via the laser fiber.
Study: NCT00184262

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: ERP cognitive therapy
Description: 15 exposure and response prevention (ERP) sessions in 3 months with a cognitive therapy rationale

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ERP behavioral therapy
Description: 15 exposure and response prevention (ERP) sessions in 3 months with a behavioral therapy rationale
Study: NCT04360564

Intervention type: OTHER
Intervention: Recurrent pregnancy loss
Description: As described before.

Intervention type: OTHER
Intervention: Recurrent pregnancy loss
Description: As described before.

Intervention type: OTHER
Intervention: Recurrent pregnancy loss
Description: As described before.
Study: NCT02244580

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MammaTyper™
Description: MammaTyper™ kit is a molecular in vitro diagnostic test for the quantitative detection of the ribonuclease acid (RNA) expression status of the genes for estrogen receptor (ESR1), progesterone receptor (PGR), human epidermal growth factor receptor 2 (HER2) and proliferation antigen KI 67.
Study: NCT03175094

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Holistic Health Recovery Program for HIV+
Description: Holistic Health Recovery Program for HIV+ (HHRP+) is a CDC-recommended, evidence based behavioral (psychoeducational) group intervention focused on harm reduction principles. The investigators systematically adapted HHRP+ using findings from qualitative interviews with the target population of adult women living with and at-risk for HIV who are justice-involved (on probation, parole, or recently released from prison or jail).
Study: NCT01398891

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Positive Psychology Exercises
Description: At each session, the interventionalist will prepare the subject to complete a randomly-selected positive psychology exercise, lasting approximately 20 minutes, within the next 24 hours. He or she will describe the rationale for the exercise and the details of the exercise, and will answer any questions. A sheet with written instructions (matching the verbal instructions) for the exercise will be provided, with space for recording the exercise and an area to provide ratings on the exercise. On the following day, the interventionalist will review the prior day's exercise (and record whether it was completed). The exercises will be completed daily on weekdays for a maximum of 8 days.
Study: NCT01100411

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Air Optix Aqua
Description: Contact lens material: Lotrafilcon A

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Biofinity
Description: Contact lens material: Comfilcon A

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Proclear
Description: Contact lens material: Omafilcon A

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Acuvue Oasys
Description: Contact lens material: Senofilcon A

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Acuvue 2
Description: Contact lens material: Etafilcon A

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Purevision
Description: Contact lens material: Balafilcon A
Study: NCT00972803

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pistacia Mutica extract
Description: The subjects were asked to use a mouthwash containing pistacia Mutica extract twice a day for 4 days.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The subjects were asked to use a placebo mouthwash twice a day for 4 days.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chlorhexidine
Description: The subjects were asked to use a mouthwash containing Chlorhexidine twice a day for 4 days.
Study: NCT00911261

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxymorphone Extended Release
Description: * Study Medication: Oxymorphone ER 5 mg, 10 mg, 20 mg, and 40 mg tablets~* Rescue Medication: Oxymorphone IR 5 mg and 10 mg tablets~* Treatment will consist of up to 12 months of dosing with Oxymorphone ER.
Study: NCT02600637

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MBSR
Description: Mindfulness-based Stress Reduction is an 8-week course designed to teach a number of mindfulness techniques to help improve stress- and depression-related symptoms.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Brain Health class
Description: An 8-week course on brain health will be administered to participants as an active control group.
Study: NCT03345927

Intervention type: OTHER
Intervention: no intervention
Description: no intervention
Study: NCT00133276

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Escitalopram
Description: OD 5mg for 2 weeks; OD 10mg for 24 weeks; OD 5mg for 2 weeks

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study: NCT04393961

Intervention type: DEVICE
Group type: OTHER
Intervention: Premier Biotech COVID-19 IgG/IgM Rapid test Cassette
Description: Current emergency situation, there are large numbers of COVID-19 Antibody tests being made available at a record pace.~The protocol is designed to be test agnostic. However, for this first volley, we have chosen the The COVID-19 IgG and IgM Rapid Test provided by Premier Biotech.~We chose the Precision Bio test for 4 reasons~1. It is available as a single use test kit in one sealed unit.~2. It's a rapid test, with results available in 10 minutes.~3. It has clear and easy to read instructions already included~4. It has one of the lowest false positive rates of known tests at the moment

Intervention type: DEVICE
Group type: OTHER
Intervention: Premier Biotech COVID-19 IgG/IgM Rapid test Cassette
Description: Current emergency situation, there are large numbers of COVID-19 Antibody tests being made available at a record pace.~The protocol is designed to be test agnostic. However, for this first volley, we have chosen the The COVID-19 IgG and IgM Rapid Test provided by Premier Biotech.~We chose the Precision Bio test for 4 reasons~1. It is available as a single use test kit in one sealed unit.~2. It's a rapid test, with results available in 10 minutes.~3. It has clear and easy to read instructions already included~4. It has one of the lowest false positive rates of known tests at the moment

Intervention type: DEVICE
Group type: OTHER
Intervention: Premier Biotech COVID-19 IgG/IgM Rapid test Cassette
Description: Current emergency situation, there are large numbers of COVID-19 Antibody tests being made available at a record pace.~The protocol is designed to be test agnostic. However, for this first volley, we have chosen the The COVID-19 IgG and IgM Rapid Test provided by Premier Biotech.~We chose the Precision Bio test for 4 reasons~1. It is available as a single use test kit in one sealed unit.~2. It's a rapid test, with results available in 10 minutes.~3. It has clear and easy to read instructions already included~4. It has one of the lowest false positive rates of known tests at the moment

Intervention type: DEVICE
Group type: OTHER
Intervention: Premier Biotech COVID-19 IgG/IgM Rapid test Cassette
Description: Current emergency situation, there are large numbers of COVID-19 Antibody tests being made available at a record pace.~The protocol is designed to be test agnostic. However, for this first volley, we have chosen the The COVID-19 IgG and IgM Rapid Test provided by Premier Biotech.~We chose the Precision Bio test for 4 reasons~1. It is available as a single use test kit in one sealed unit.~2. It's a rapid test, with results available in 10 minutes.~3. It has clear and easy to read instructions already included~4. It has one of the lowest false positive rates of known tests at the moment
Study: NCT02120976

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JTT-252 or Placebo
Description: Subjects will receive JTT-252 or Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JTT-252 or Placebo
Description: Subjects will receive JTT-252 or Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JTT-252 or Placebo
Description: Subjects will receive JTT-252 or Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JTT-252 or Placebo
Description: Subjects will receive JTT-252 or Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JTT-252 or Placebo
Description: Subjects will receive JTT-252 or Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JTT-252 or Placebo
Description: Subjects will receive JTT-252 or Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JTT-252 or Placebo
Description: Subjects will receive JTT-252 or Placebo
Study: NCT04528680

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemotherapy, albumin-bound paclitaxel
Description: Intravenous infusion of ABX over 30 minutes
Study: NCT02120976

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JTT-252
Description: Subjects will receive JTT-252

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JTT-252
Description: Subjects will receive JTT-252
Study: NCT04488120

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: transcatheter closure of secundum atrial septal defects in patients
Description: transcatheter closure of secundum atrial septal defects in patients

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcatheter closure of secundum atrial septal defects in patients
Description: transcatheter closure of secundum atrial septal defects in patients
Study: NCT03010878

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Yoga
Description: The yoga intervention group addressed pain as a primary variable and balance as a secondary variable and how to best manage these symptoms in the clinic and community.~Yoga was delivered in sitting, standing, and floor postures

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Self-management
Description: The self-management education group was provide once a month through University of Colorado Health Fort Collins Family Medicine Residency Program Pain Management Clinic. The program consisted of lifestyle variations, accountability, modifications, and strategies to management pain in daily life.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Self-management
Description: The self-management education group was provide once a month through University of Colorado Health Fort Collins Family Medicine Residency Program Pain Management Clinic. The program consisted of lifestyle variations, accountability, modifications, and strategies to management pain in daily life.
Study: NCT04528680

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemotherapy, carboplatin
Description: Intravenous infusion of carboplatin over 30 minutes
Study: NCT03864237

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Alcohol texts
Description: A text message each day for 10 weeks, containing factual information about campus drinking norms.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Attention control
Description: A text message each day for 10 weeks, containing this day in history facts.
Study: NCT04848740

Intervention type: DEVICE
Group type: OTHER
Intervention: ReLex-smile
Description: Using VisuMax femtosecond laser we created the stromal pocket with diameter of 7.6 to 8.0 mm (1 mm larger than the optical zone of the donor lenticule) and cap thickness set to 130 μm from corneal surface and 4 mm superior incision. Hinge position flap was set at 90° angle 50° and width 4 mm, side cut angle 90°. The pocket was dissected using a blunt spatula washed with normal saline. The lenticule was held with lenticule forceps and gently inserted into the pocket through the 4 mm superior incision. Incision position changed according to the position of the highest K values We noticed during intervention that implantation of fresh lenticule depends from corneal thickness, for example if c.th.is 300-400 μm we implanted 1/2 stroma, if c.th.is 400 μm or more we implanted 1/3 stroma Example: if corneal thickness is 300 μm we implanted 150 μm (becoming 450 μm) we added more stroma due to more live keratocytes and stromal steam cells, aiming to overcome dead and non-functional keratocytes
Study: NCT02364856

Intervention type: DEVICE
Intervention: Analgesia Nociception Index
Description: The Analgesia Nociception Index (ANI, MDoloris Medical Systems, Lille, France), based on Heart Rate Variability analysis, measures continuously and non-invasively the influence of Respiratory Sinus Arrhythmia on the heart rate. This 0-100 index indicates the proportion of paraS over sympathetic activity. In adults during surgery under general anesthesia, ANI decreases after painful stimulation and has been related to the balance between analgesia and nociception.~ANI is calculated from heart rate recording.
Study: NCT01474356

Intervention type: OTHER
Group type: NO_INTERVENTION
Intervention: hyperthermia
Description: 45 minutes of interstitial heating 42.5-49°C during the interstitial brachytherapy
Study: NCT02982122

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: For both groups, CPP targets will be achieved first by ICP control if this is raised and then by ABP support by titration (up or down) of vasopressors and fluids according to local protocols.
Description: For both groups, CPP targets will be achieved first by ICP control if this is raised and then by ABP support by titration (up or down) of vasopressors and fluids according to local protocols.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: For both groups, CPP targets will be achieved first by ICP control if this is raised and then by ABP support by titration (up or down) of vasopressors and fluids according to local protocols.
Description: For both groups, CPP targets will be achieved first by ICP control if this is raised and then by ABP support by titration (up or down) of vasopressors and fluids according to local protocols.
Study: NCT01474356

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: hyperthermia
Description: 45 minutes of interstitial heating 42.5-49°C during the interstitial brachytherapy
Study: NCT03924362

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PCNL
Description: Percutaneous Nephrolithotomy is a means of treating large kidney stone burdens.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PCNL
Description: Percutaneous Nephrolithotomy is a means of treating large kidney stone burdens.
Study: NCT01351961

Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Urine sample
Study: NCT01858766

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SOF
Description: 400 mg tablet administered orally once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SOF
Description: 400 mg tablet administered orally once daily
Study: NCT01736488

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fimasartan
Description: Fimasartan 60mg
Study: NCT03777293

Intervention type: DEVICE
Group type: OTHER
Intervention: ultrasound viscoelasticity
Description: use these devices to do ultrasound examination in chronic liver disease patients
Study: NCT04259749

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Flavor Ban
Description: Only flavored tobacco products are banned
Study: NCT03777293

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ultrasound viscoelasticity
Description: use these devices to do ultrasound examination in chronic liver disease patients
Study: NCT03553732

Intervention type: OTHER
Intervention: Registry
Description: Patients who are diagnosed with prostate cancer and elect to be monitored by an Active Surveillance protocol by the Urology Clinic at Zuckerberg San Francisco General Hospital and Trauma Center will be included in this group. The intervention is the implementation of a registry, designed to replace existing but suboptimal systems for tracking patients. All Active Surveillance patients monitored by the clinic will be included.
Study: NCT01611181

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hemoboost
Description: 200 mg specially processed haemoglobin and 30 mg iron dextran equivalent to 10.5 mg organically bound iron in 1 tablet twice daily.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Kräuterblut
Description: 40 mg iron, 20 ml twice daily.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ferrofumerat
Description: 200 mg ferrous sulphate as 1 tablet twice daily.
Study: NCT02858245

Intervention type: OTHER
Intervention: No intervention - registry
Study: NCT03843879

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transversus Abdominis Plane Block
Description: Single-injection transversus abdominis plane block with 30 mL of 0.25% Bupivacaine with 1:400,000 epinephrine

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous Lidocaine
Description: Continuous intravenous lidocaine infusion
Study: NCT02643654

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: MABp1
Description: This is a sterile injectable liquid formulation of 50 mg/mL MABp1 in a stabilizing isotonic buffer (pH 6.4). Each 10-mL serum vial contains 6 ml of the formulation, and is sealed with a 20-mm grey bromobutyl stopper and flip-off aluminum seal

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo dosage form is a sterile isotonic formulation buffer at pH 6.2-6.5. Each 10-ml Type I borosilicate glass serum vial contains 6mL of the formulation buffer, and is sealed with a 20-mm Daikyo Flurotec butyl rubber stopper and flip-off aluminum seal.
Study: NCT00504686

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: manual therapy
Description: manual therapy - thoracic spine thrust manipulation
Study: NCT00504686

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: exercise
Description: therapeutic exercise

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: exercise
Description: therapeutic exercise
Study: NCT04259749

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Menthol Ban
Description: Mentholated products are banned

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: All flavored and mentholated products available
Description: No bans: All tobacco products are available
Study: NCT01579240

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Internet exercise program
Description: 12 voluntary weekly visits to website
Study: NCT04201652

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Superficial local anesthetic infiltration
Description: Superficial infiltration of local anesthetic for carpal tunnel release.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Deep local anesthetic infiltration
Description: Deep and superficial infiltration of local anesthetic for carpal tunnel release.
Study: NCT02895386

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ROX Coupler
Description: ROX Coupler will be used to create an anastomosis in the iliac region (between the iliac artery and vein).

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham procedure
Description: Sham procedure + continuing current antihypertensive medications.
Study: NCT03861260

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Rigid cystoscopy with urethral dilatation
Description: Patients will have a general anaesthetic and a rigid cytoscopic examination of the bladder dilated with sterile water. The urethra will be dilated from FR20 in incremental diameter increases of 2 to French 32 if possible.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Flexible cystoscopy and installation of Glycosaminoglycan layer replacement (laluril)
Description: Patients will undergo flexible cystoscopy and intravesical installations of Hyaluronic acid (HA) + Chondroitin Sulphate (CS) (GAGs) weekly for 4 weeks and then at 8 weeks and 12 weeks.
Study: NCT02038595

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: PET imaging
Study: NCT02883296

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pelvis Magnetic resonance imaging
Study: NCT02651740

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifaximin
Description: 400mg tid\* 3d

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation
Description: Using filtered fresh donor stool, 100-200ml per time throuth enteral nutrition tube for at least one time
Study: NCT04411316

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Catheter directed thrombolysis plus anticoagulation
Description: Patients will be randomized to pharmacomechanical catheter directed thrombolysis plus anticoagulation.~PCDT will be AngioJet along with alteplase.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Anticoagulation
Description: Patients will receive anticoagulation alone. Anticoagulation will be heparin only.
Study: NCT01489449

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Stent
Description: bare metal stent implantation, any bare metal stent is allowed from different companies

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: SeQuent(R) Please coated balloon
Description: Angioplasty with Drug coated balloon (DCB)
Study: NCT01475539

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Injectable inactivated types 1, 2 and 3 poliovirus + Live oral Polio
Description: 0.5 mL, Intramuscular + 1g dragee candy oral dose
Study: NCT01475539

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Injectable inactivated types 1, 2 and 3 poliovirus + Live oral Polio
Description: 0.5 mL, Intramuscular + 1g dragee candy oral dose

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Live oral poliovirus type 1, 2 and 3
Description: 1g dragee candy, oral
Study: NCT01736488

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Atenolol
Description: Atenolol 50mg
Study: NCT02841020

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Additional biopsy
Description: • Patients in the experimental group receive the additional biopsy for non-neoplastic disease during the same procedure before the biopsy of the renal mass (with potential for direct benefit to the patient by revealing non-neoplastic renal disease).
Study: NCT04180696

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: aCRT ON
Description: CRT device with AdaptivCRT enabled
Study: NCT01625559

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MA09-hRPE
Description: MA09-hRPE cells